Physician profile
Chad Metzger
NPI 1184074783
$14,338.77
in general payments reported to CMS, 2019-2025
34 companies · $1,607 in 2025
The $1,607 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $241 · 2021: $3,131 · 2022: $4,706 · 2023: $2,802 · 2024: $1,852 · 2025: $1,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,260.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,889.10 | 2021-2022 | |
| Abbott Laboratories | $2,876.66 | 2022-2025 | Eterna, Proclaim, Octrode |
| Mml US, INC. | $2,129.43 | 2022-2023 | Reactiv8 |
| Boston Scientific Corporation | $1,757.47 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Nevro Corp. | $874.74 | 2021-2024 | Senza |
| Vertos Medical, INC. | $763.88 | 2021-2024 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $512.67 | 2022-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $445.04 | 2021-2025 | Xtampza, Belbuca |
| Foundation Fusion Solutions, LLC | $239.67 | 2021-2025 | |
| Medtronic USA, INC. | $194.55 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $183.98 | 2021-2024 | Relistor |
| Stryker Corporation | $167.55 | 2025 | Mild Device Kit |
| Painteq LLC | $160.61 | 2021-2024 | Painteq |
| Abbvie INC. | $158.05 | 2022-2025 | |
| Ibsa Pharma INC. | $118.86 | 2024-2025 | Tirosint, Licart, Flector |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $91.14 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $80.85 | 2025 | |
| Si-Bone, INC. | $79.85 | 2024 | |
| Averitas Pharma INC. | $78.96 | 2023-2025 | Qutenza |
| Valinor Pharma, LLC | $70.57 | 2023-2024 | Movantik |
| Spr Therapeutics, INC | $66.00 | 2023 | Sprint Pns System |
| Forte Bio-Pharma LLC | $65.30 | 2021-2022 | |
| Lilly USA, LLC | $57.11 | 2021-2023 | Reyvow, Emgality |
| Spinal Simplicity, LLC | $44.88 | 2025 | Ha Minuteman G3-R |
| Grt US Holding, INC. | $34.12 | 2021 | |
| Stimwave Technologies Incorporated | $34.00 | 2021 | |
| Axsome Therapeutics, INC. | $31.99 | 2023 | Sunosi |
| Pfizer INC. | $26.92 | 2025 | |
| Lundbeck LLC | $22.93 | 2025 | Vyepti |
| Almatica Pharma LLC | $20.38 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.62 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.35 | 2022 | |
| Currax Pharmaceuticals LLC | $12.84 | 2023 | Onzetra Xsail |
| Kowa Pharmaceuticals America, INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Metzger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.